
Testing Status of Agents at NTP

Testing Status of Agents at NTP
Home » Testing Information » Testing Status of Agents at NTP » Methylamine » Executive Summary Methylamine
Human Data:
No epidemiological studies or
case reports investigating the association of exposure to methylamine
and cancer risk in humans were identified in the available literature.
However, the formation of the carcinogen N-nitrosodimethylamine
(NDMA) when large amounts of nitrate were added to human gastric
fluid which contained methylamine was reported by Zeisel et
al. (1988). The ACGIH (1993) summarized available human study
information as follows. Transient eye, nose, and throat irritation
was produced by brief exposure at 20 to 100 ppm methylamine.
No evidence of irritation was produced from exposure at less than
10 ppm. In an unpublished report, allergic or chemical bronchitis
was reported in a worker exposed to methylamine at concentrations
ranging from 2 to 60 ppm; and some irritation was noted at about
25 ppm. It is unclear from the report what the actual exposure
concentrations were. No accounts of long-term effects, systemic
reactions, and skin sensitization have been reported in the literature.
Although there is limited human exposure data, it appears that
there is evidence of irritation at 25 ppm and no or minimal irritation
at 10 ppm.
Animal Data:
Acute
Methylamine has not been evaluated for skin absorption
potential; however, it has been shown to be irritating to the
skin of guinea pigs and the eyes of rabbits, and may be irritating
to the gastrointestinal tract of guinea pigs following oral administration
(Goffman & McGuire, 1980; ACGIH, 1993).
Reported acute toxicity values are presented in
Table 7..
Recent studies on the comparative pulmonary toxicity
of methyl isocyanate (MIC) and its hydrolytic derivatives in Wistar
rats found that single exposure by both the inhalation (19mmol/l
of methylamine vapors for 30 minutes) and subcutaneous (sc) routes
(5.75 mmol/kg) caused interstitial pneumonitis at the acute (24
hours), subacute (4 weeks) and chronic (10 weeks) phases progressing
to fibrosis, suggesting involvement in the subsequent inflammatory
response and contribution to the long-term pulmonary damage of
MIC (Jeevaratnam & Sriramachari, 1994; Sriramachari &
Jeevaratnam, 1994).
Subchronic
Groups of 10 male rats were exposed by nose-only
inhalation (6 hours/day, 5 days/week) for 2 weeks to 75,
250, or 750 ppm of methylamine (99.9% pure). Rats were sacrificed
immediately following exposure or following a 14-day recovery
period. Exposure to 75 ppm produced mild irritation to the nasal
turbinate. Exposure to 250 ppm produced mild, irreversible focal
erosion and/or ulceration of the respiratory mucosa of the nasal
turbinates. Exposure to 750 ppm produced toxic effects including
mortality, severe body weight loss, clinical pathologic changes
suggestive of liver damage, nasal degenerative changes, and hematopoietic
changes; not all effects were reversible during the recovery period
(Kinney et al., 1990).
Chronic/Carcinogenicity
No 2-year carcinogenicity studies of methylamine
in animals were identified in the available literature. However,
the in vivo conversion of amines to nitrosamines has been
reported in the literature. Nitrosamines are known animal carcinogens,
and there is evidence to suggest that nitrosamines have carcinogenic
potential for humans. The extent of this conversion and relevance
to human cancer have not yet been determined (ACGIH, 1993).
Several chemical reaction studies and animal studies
have reported that methylamine reacts to form carcinogens and
precursor chemicals, including NDMA, N-nitrosomethyl-methoxymethylamine
(NMMA), methylurea, and azoxymethane. These studies are summarized
below.
Short-Term Tests: Methylamine was not mutagenic
with or without metabolic activation (S9) in the Salmonella
preincubation assay when tested at doses up to 10,000mg/plate
in strains TA98, TA100, TA1535, and TA1537 (Mortelmans et al.,
1986); when tested in the dose range 0.03729.44 mg/plate
(corrected dose for 0.08-64 mg/plate of methylamine hydrochloride)
in strains TA98, TA100, and TA104; or when tested in strains TA97a
or TA102 (Meshram et al., 1992).
Methylamine (dose range 0.25, 0.5, 1.0 M) in combination
with nitrite (0.25 or 0.5 M) was mutagenic in Escherichia coli
Sd-4 (Hussain & Ehrenberg, 1974). Methylamine and 2aminoethanol
also enhanced the mutagenic effect of ethyl nitrite in E. coli.
The authors noted that the synergistic action of primary amines
could be interpreted as a mutagenic action of monoalkylnitrosamines
which are rapidly converted to the corresponding highly reactive
diazonium ions (Ehrenberg et al., 1980).
Methylamine induced mutagenic responses at the
tk locus in the mouse lymphoma cell forward mutation assay in
the absence of S9 at concentrations in the range of 200-300 nl/ml
(3-4 mM) and became lethal at approximately 400 nl/ml (5mM) (Caspary
& Myhr, 1986; Shelby et al., 1987). A rat inhalation
dominant lethal test found that methylamine was mutagenic at 10
µg/m3
(NLM, 1995).
Huber & Lutz (1984a,b) showed in vitro
and in vivo methylation of DNA, indicative of DNA damage,
from the reaction of methylamine and nitrite. Increased amounts
of 7-methylguanine were detected when DNA from calf thymus was
incubated with 1.2 mM methylamine (as the hydrochloride) and up
to 66.0 mM sodium nitrite (78.8, 78.8, 50.4 mM) and in the stomach
and small intestine of male Sprague-Dawley rats gavaged with methylamine
(30µmol/kg
bw as the hydrochloride) and sodium nitrite (700µmol/kg
bw). Methylation of DNA in vivo was at least 330 times
lower than after an in vitro incubation of DNA with the
reactants.
Tsimis & Yarosh (1990) demonstrated the induction
of the adaptive response to DNA alkylation, in which DNA repair
genes are coordinately induced to express enzymes which reduce
the toxic and mutagenic effects of DNA damage, in E. coli
MV1601 cells treated with methylamine and nitrite. The adaptive
response was induced in proportion to the concentration of methylamine
up to a peak at 40 mM. No induction was observed either with
nitrite and no methylamine, or with methylamine and no nitrite.
Inhibition of bacterial nitrosation provided additional evidence
that the induction of the adaptive response was due to nitrosation
of methylamine. The authors suggested that the adaptive response
evolved as a defense against environmental mutagens produced by
bacteria themselves.
Metabolism: Zeisel and coworkers (1983)
reported that humans and rats excrete methylamine in their urine
after eating choline or lecithin, compounds found in many common
foodstuffs. They found that almost 1 mmol per day of methylamines
was excreted in the urine of humans who consumed a normal diet,
almost 2 mmol/day after consumption of 27 mmol of choline chloride,
and 0.8 mmol/day after ingestion of lecithin. Rats excreted
0.015 to 0.018 mmol/day of methylamine after consuming a choline-free
diet. Excretion of methylamine was similar after administration
of 2 mmol/kg b.w. of choline chloride or lecithin. They noted
that these methylamines could be substrates for the formation
of carcinogenic nitrosamines.
In a later study, Zeisel and coworkers (1988) showed
that biological fluids from fasting humans and experimental animals
contained methylamine. In humans that had fasted overnight, the
concentration of methylamine in gastric fluid (3.7 nmol/ml) was
similar to that in saliva (5.0 nmol/ml) and blood (3.8
nmol/ml), but was lower than that in urine (156.4 nmol/ml). The
concentration of methylamine in the gastric fluid of dogs (11.8
nmol/ml), ferrets (17.4 nmol/ml), or rats (23.1 nmol/ml) was considerably
higher, possibly reflecting differences in metabolism or in the
amine content of the diet. When large amounts of nitrite were
added to the human gastric fluid, NDMA was formed.
The toxicokinetics of methylamine has been studied
in the rat. Streeter and coworkers (1990) observed biphasic first-order
elimination following a single intravenous (iv) bolus dose of
18.9 µmol/kg
[14C]- methylamine with a terminal half-life of 19.1
minutes. The apparent steady state volume of distribution, systemic
blood clearance, and renal blood clearance were 1.21 liter/kg,
53.4 ml/min/kg, and 5.72 ml/min/kg, respectively. The amount
of unchanged methylamine excreted in the urine within 24 hours
was 10%. Urinary excretion of total radioactivity was 12.3%,
in good agreement with a value of 12% reported for intraperitoneal
(ip) doses of 7.5 µmol/kg
in the rat by Krishna & Casida (1966). In another study in
rats, Schwartz (1966) found 24% of the unchanged compound in the
urine following an ip dose of 400µmol/kg.
Streeter et al. (1990) commented that this was probably
the result of saturation of the metabolic capacity of the animal
leading to more methylamine being eliminated unchanged in the
urine. Streeter and coworkers (1990) also administered a single
intragastric (ig) dose of 81.9 µmol/kg
[14C]-methylamine to male rats and found that 69% of
the dose reached the systemic circulation unchanged out of a total
of 93% absorbed from the gut.
Reported metabolites of methylamine include monomethylurea
(Dar & Bowman, 1985) and formaldehyde and formate as metabolic
intermediates in the conversion of methylamine to carbon dioxide
(Keefer et al., 1987). Carbon dioxide has been reported
to account for approximately 50% of the elimination of methylamine
in rats administered the compound ip (Krishna & Casida, 1966;
Dar et al., 1985). Streeter and coworkers (1990) noted
that a similar extensive conversion to this metabolite would be
expected following an iv dose. Methylamine can be metabolized
in the rat to dimethylamine to a small extent (Asatoor & Simenhoff,
1965).
Studies by Krishna & Casida (1966) and Schwartz
(1966) determined that negligible amounts of unchanged methylamine
were excreted in the expired air following ip doses of 7.5 or
400 µmol/kg
to male rats.
Krishna & Casida (1966) did not observe accumulation
of radioactivity in the fat of rats at 48 hours after dosing
with [14C]-methylamine. Steeter and coworkers (1990)
commented that high lipophilicity with resulting accumulation
in the fat is not likely to occur since methylamine would be expected
to be ionized at physiological pH values.
Semicarbazide-sensitive amine oxidase (SSAO) in
homogenates of rat aorta, porcine aorta, human umbilical artery,
and rat white and brown adipose tissue showed deaminating activity
towards methylamine. Formaldehyde was the metabolic product of
methylamine deamination by SSAO from rat and porcine aorta (Precious
et al., 1988; Boor et al., 1992; Conforti et
al., 1993). Measurement of urinary levels in rats, before
and after treating them with drugs capable of inhibiting either
SSAO or mitochondrial monoamine oxidase (MAO) activities, indicated
that MAO is not involved in methylamine degradation. These results
were consistent with the possibility that SSAO, or related enzymes,
may be involved in endogenous methylamine turnover (Lyles &
McDougall, 1989). Streeter and coworkers (1990) commented that
if SSAO is able to metabolize methylamine in vivo in the
rat, not all of the dose would reach the venous sampling site
following iv administration, with a consequent overestimation
of the apparent volume of distribution at steady state. They
also noted that an overestimation of the apparent volume of distribution
at steady state might occur if an uptake process were occurring
in the liver or other organs of the rat because the concentration
at the sampling site would not be representative of that within
the tissues. Solheim & Seglen (1983) found that isolated
hepatocytes can accumulate methylamine intracellularly to concentrations
in excess of those in the extracellular medium.
Methylamine is also a substrate for the related
soluble enzyme, human plasma oxidase (McEwen, 1965).
Methylamine is formed in rats from the metabolism
of endogenous compounds such as epinephrine (Schayer et al.,
1952), sarcosine, glycine, and creatine (Davis & deRopp, 1961).
It is also a metabolite of a large number of xenobiotics such
as nicotine (McKennis et al., 1962), carbaryl in rats (Krishna
& Casida, 1966), N-methylformamide in rats and mice (Threadgill
et al., 1987; Tulip & Timbrell, 1988), dazomet in rats
and mice (Lam et al., 1993), metham in mice (Lam et
al., 1993), methylhydrazine in rats (Schwartz, 1966), azoxymethane
in rats (Fiala et al., 1978), and NDMA in rats (Heath &
Dutton, 1958; Burak et al., 1991).
Other Biological Effects:
Reproductive Effects/Teratology
In reproduction studies in which 6 female Wistar
rats were orally administered 5 mg/kg bw methylamine daily and
mated to untreated males, Sarkar and Sastry (1990) found no effect
on the estrous cycle, reproductive indices of fertility, gestation,
live birth, lactation, the average weight of pups at birth, and
weaning. However, the average litter size of the treated group
decreased significantly (P < 0.05) from the control group.
The investigators noted that this effect may be due to either
resorption of the fetus or some other reason. In an earlier study
in rats, Miller (1971) found that a single intracardial injection
of methylamine hydrochloride (dose not stated) on day 13 of gestation
did not result in any gross malformations.
The reproductive toxicity of methylamine has also
been studied in mice. Methylamine did not exert any maternal
or fetal toxicity when injected ip (3 mmol/kg) during midgestation
(day 8) to pregnant Swiss mice or when injected ip at levels up
to 5 mmol/kg (as the hydrochloride salt) from days 1 to 17 of
gestation to groups of pregnant CD-1 mice (6-8 animals per group)
(Varma et al., 1990; Guest & Varma, 1991). When cultured
for 48 hours with 8-day-old mouse embryo cells, however, methylamine
(0.75, 1.0, 2.0 mM) caused dose-dependent decreases in size, DNA,
RNA, and protein content as well as embryo survival, suggesting
teratogenic potential. The authors speculated that methylamine
may act as an endogenous teratogen under certain conditions (Guest
& Varma, 1991).
Structure/Activity Relationships: Four structurally
related chemicals were selected for evaluation of relative biological
effects. A summary of information found in the available literature
is presented in Table 8 followed by a more detailed discussion.
No information on carcinogenicity or mutagenicity for the structurally
related compound n-propylamine [107-10-8] was found. Information
on carcinogenicity was identified for only one of the compounds.
Dimethylamine was nontumorigenic in rats by the oral route and
negative results were also seen in rats and mice following inhalation
assays. Mutagenicity data were available on three of the structurally
related compounds. Test results were negative for two of these
compounds, trimethylamine and ethylamine. Although most indicators
of genotoxicity were negative for dimethylamine, three studies
reported some activity. It was weakly mutagenic in S. typhimurium
strain TA1530, positive in Saccharomyces cerevisiae strain
D7, and marginally active in Chinese hamster ovary (CHO) cells
for chromosomal aberrations (CA) and sister chromatid exchange
(SCE). The formation of carcinogenic nitrosamines from the interaction
of nitrite and dimethylamine or trimethylamine has been reported.
In addition, pyrolysates of dimethylamine and trimethylamine
have exhibited mutagenicity in S. typhimurium strains TA98
and TA100.
Carcinogenic Effects
Dimethylamine. In a 2-year inhalation study, groups of
95 male and female F344 rats and B6C3F1 mice were exposed to 0,
10, 50, or 175 ppm dimethylamine for 6 hours/day, 5 days/week.
Histopathological examinations at 6, 12, 18, and 24 months found
no evidence of a carcinogenic response. Concentration-dependent
toxicity was characterized by decreased body weight (175 ppm only)
and progressive inflammatory, degenerative, and hyperplastic lesions
of the nasal passages (Buckley et al., 1985; CIIT, 1990).
Dimethylamine was nontumorigenic when 27 noninbred rats (sex
not stated) were fed 1.6 g/kg diet for 2.5 years (PHS-149, 1979-1980;
ACGIH, 1993).
A secondary or tertiary amine may react with nitrite under acidic
conditions to give the carcinogenic nitroso compound (Ohshima
& Kawabata, 1978).
Mutagenic Effects
Dimethylamine. At concentrations of 0.05-0.5 M with metabolic
activation, dimethylamine was weakly mutagenic in S. typhimurium
strain TA1530. It was not mutagenic in TA1530 without activation
or in TA1531, TA1532, or TA1964 with or without activation. At
800 mg/kg it was also negative in the host-mediated assay with
strains TA1950, TA1951, TA1952, and TA1964 (Green & Savage,
1978). At up to 4500 µg/plate, dimethylamine
was negative with and without activation in S. typhimurium
TA100, TA1535, TA1537 and TA98 (Zeiger et al., 1987).
Dimethylamine was negative in strain Sd-4-73 of E. coli
(dose not stated) (Szybalski, 1958). A dose dependent increase
in convertants and revertants was observed in S. cerevisiae
strain D7 when dimethylamine was tested at a maximal dose of 4
mM with S9 (Galli et al., 1993). In CHO cells, dimethylamine
did not exhibit cytotoxic or mutagenic effects at up to 22 mM
even with S9, and marginal effects on SCE and chromosome aberrations
were seen in the presence of S9 (Hsie et al., 1987). Dimethylamine
(dose not stated) was negative for chromosome aberrations in Chinese
hamster lung fibroblasts with or without activation (Ishidate
et al., 1981). It was also negative for UDS in rat hepatocytes
at 3.3 mM (Martelli et al., 1983).
When dimethylamine hydrochloride was pyrolysed at 300°
to 600°C for 3 minutes, the pyrolysates were mutagenic in
S. typhimurium strains TA98 and TA100 with activation.
The pyrolysates were also slightly mutagenic in TA100 without
activation. At doses of 5-20 µmol,
the mutagenic activity began to appear from the pyrolysates at
400°C and the pyrolysates at 600°C showed the highest
mutagenic activity (Ohe, 1982).
Trimethylamine. No evidence for mutagenic activity of
trimethylamine in S. typhimurium strains TA1535, TA1537,
TA98, and TA100 was detected at doses up to 1,000 <µg/plate
with or without activation (Mortelmans et al., 1986).
When trimethylamine hydrochloride was pyrolysed at 300°
to 600°C for 3 minutes, the pyrolysates were mutagenic in
S. typhimurium strains TA98 and TA100. The pyrolysates
at 600°C showed the highest mutagenic activity (Ohe, 1982).
Ethylamine. Ethylamine was negative when tested for mutagenicity
in S. typhimurium strains TA100, TA1535, TA1537, and TA98
at doses up to 10,000 µg/plate. The
preincubation assay was performed both with and without activation
(Mortelmans et al., 1986). Ethylamine was inactive when
administered in a mouse in vivo system to assess testicular
DNA synthesis inhibition following intraperitoneal doses of 5,
15, or 50 mg/kg (Seiler, 1981).
Web page last updated on August 15, 2005
The National Institute of Environmental Health Sciences is one of the National Institutes of Health within the U.S. Department of Health and Human Services. The National Toxicology Program is headquartered on the NIEHS campus in Research Triangle Park, NC.